News

Simulations Plus Faces Investigation After Auditor Dismissal

Simulations Plus Faces Investigation After Auditor Dismissal

Simulations Plus, Inc. Investigated for Securities Violations

Recently, Simulations Plus, Inc. (NASDAQ: SLP), a leader in simulation software for pharmaceutical and biotechnology industries, has found itself embroiled in a significant legal situation. The firm, known for its innovative modeling and simulation tools, is currently under investigation for possible violations of federal securities laws. This investigation has arisen after the dismissal of its independent auditor, sparking concerns among investors and the market.

Background on the Company

Simulations Plus specializes in developing software solutions that help streamline processes in the pharmaceutical and biotech sectors. Their recent acquisition of Pro-ficiency Holdings, Inc. aimed at enhancing their capabilities in providing simulation-based training and compliance solutions. However, this acquisition is problematic as it appears to have adversely affected the company’s operational integration and internal financial controls.

Key Issues with Financial Reporting

In the months following the acquisition, Simulations Plus assured its shareholders that the merger would expand its market reach and significantly boost sales. Unfortunately, that was not the reality. Reports indicate that the firm struggled with integrating Pro-ficiency effectively and acknowledged weaknesses in its internal controls. These revelations have led to the current judicial scrutiny.

Stock Price Declines Amidst Uncertainty

On June 11, 2025, following a disappointing earnings forecast, Simulations Plus announced that it was facing substantial market uncertainties, including issues surrounding funding and drug pricing. The stock plummeted by over 24% in just one day after these results were disclosed. The decline marked a troubling downward trend for the company, exacerbating investor fears.

Auditor Dismissal and Its Fallout

Adding to the turmoil, the company’s decision on July 14, 2025, to fire its auditor Grant Thornton LLP raised even more red flags. This dismissal was attributed to unresolved issues concerning financial reporting and internal controls. Notably, the departing auditors highlighted significant disagreements with the company's management, suggesting that their evaluations of various reporting matters were unsatisfactory.

Impact on Investors

The reverberations of these events have been felt throughout the investor community. Following the news about the auditors and the accompanying charge related to prior acquisitions, Simulations Plus experienced an immediate drop in stock price from approximately $17.47 to $12.97. This 26% decline has prompted concerns that shareholders might face significant losses.

What Should Investors Consider?

For shareholders of Simulations Plus, it is crucial to stay informed during these turbulent times. Investors who feel they may have incurred a financial loss due to the recent developments are encouraged to explore their legal options. Potential avenues include participation in investigations and class action lawsuits aimed at protecting shareholder rights.

How to Take Action

Those involved have the opportunity to submit their information for consideration regarding these legal proceedings. It is important to remember that legal representation for such cases generally operates on a contingency fee basis, which means there is no upfront cost to individuals pursuing these claims.

Contact Information

If you are a shareholder worried about your investments in Simulations Plus, you can reach out for legal assistance. Contact Ross Shikowitz at Bleichmar Fonti & Auld LLP at 212.789.3619 or via email for inquiries on the ongoing investigation.

Why Choose Bleichmar Fonti & Auld LLP?

Bleichmar Fonti & Auld LLP is a well-established law firm that specializes in representing investors in securities class actions. Their expertise and track record in recovering losses for their clients during high-stakes financial scenarios highlights their capability in handling complex cases like that of Simulations Plus.

Frequently Asked Questions

What prompted the investigation into Simulations Plus?

The investigation was triggered due to concerns about the company’s financial reporting and internal controls following the dismissal of its auditor, Grant Thornton LLP.

How has the stock price been affected by these events?

Simulations Plus's stock price has dropped significantly, with noticeable declines following the announcement of disappointing financial results and auditor dismissal.

What are the options for affected investors?

Investors may consider legal action, including participation in class action lawsuits against Simulations Plus to seek reparations for losses.

Who can I contact for legal representation?

For legal representation, shareholders can contact Ross Shikowitz at Bleichmar Fonti & Auld LLP for inquiries regarding the ongoing investigation.

Is there a cost for legal representation?

Generally, legal representation for securities class action lawsuits is offered on a contingency basis, meaning investors do not have to bear upfront legal costs.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 304

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Sintilimab Poised for New Milestone in Melanoma Fight

Updated Category News Views 39

An Opening Shot: NMPA's Decision Window Well, here's the latest chapter in the saga of battling advanced melanoma with some real gritty numbers behind it. Innovent Biologics has thrown its hat back in the ring with news that the China National Medical Products Administration (NMPA) has embraced a new indication application for their drug sintilimab. They're teaming it up...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 421

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 212

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
HCLTech Partners with Rapidus on Semiconductor Future

Updated Category News Views 0

Making Sense of the HCLTech and Rapidus Collaboration When you're talking about the world of semiconductors, no two words get tossed around more than innovation and speed. Now, with the recent partnership between HCLTech and Rapidus, those words are bound to echo from India to Japan and beyond. We have HCLTech, a stalwart of global technology, teaming up with Rapidus, a...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 264

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
D-Wave Investors Must Decide by Dec 15 Class Suit

Updated Category News Views 177

Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...

Continue Reading
Clarins Dazzles Austin with Skin Longevity Event

Updated Category News Views 264

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 149

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
Dar Global Eyes Dubai for Strategic Real Estate Moves

Updated Category News Views 0

Tapping into Dubai's Real Estate Allure Every seasoned investor knows the real estate game ain't for the faint of heart, especially when you’re playing in a market as competitive as Dubai's. But here comes Dar Global Capital Partners (DGCP), throwing their hat into the ring with a fresh strategy centered around high-value real estate. Sure, they aren't new to the...

Continue Reading

Top 5 Most Recently Viewed Articles

Dandy® Celery Innovates Back-to-School Snacking Options

Updated Category News Views 53

Dandy® Celery Offers Innovative Snacking for Back-to-School Dandy® Produce, a leading name in fresh celery, is here to support families as they navigate back-to-school routines. They provide a variety of quick and healthy meal and snack options. Their fresh-cut celery sticks are a perfect addition to school lunches, afterschool snacks, and even quick sides for busy...

Continue Reading
General Dynamics (GD): Navigating Aerospace Headwinds and Opportunities

Updated Category News Views 209

General Dynamics: Current Market Dynamics General Dynamics Corporation (NYSE: GD) is widely recognized for its pivotal role in the aerospace and defense sectors. The company has a strong reputation, particularly for producing Gulfstream jets, alongside its diverse range of military and marine systems. Despite its established position, General Dynamics has been...

Continue Reading
SunCar Technology Group Inc. Enters NASDAQ Golden Dragon Index

Updated Category News Views 74

SunCar Technology Group Inc. Achieves Milestone Inclusion SunCar Technology Group Inc. (NASDAQ: SDA), a prominent player in the cloud-based B2B automotive services and insurance sector, proudly announces its recent addition to the NASDAQ Golden Dragon China Index. This significant achievement illustrates the company's upward journey and strengthens its market positioning....

Continue Reading
Strategic Investment by BrainsWay to Enhance Mental Health Solutions

Updated Category News Views 165

BrainsWay's Expansion Plans and Strategic Investment This investment marks BrainsWay’s entrance into the market for mental health therapies that can be administered outside of a clinic, including at home. Neurolief’s breakthrough Proliv™Rx device is pending Premarket Approval from the U.S. FDA, and if granted, it will set a precedent as the first FDA-cleared medical...

Continue Reading
Future Projections: Cosmetic Surgery Market Growth Insights

Updated Category News Views 97

The Expanding Cosmetic Surgery Market The cosmetic surgery market is anticipated to experience significant growth over the coming years, with projections indicating an increase from USD 56.98 billion in 2024 to approximately USD 83.34 billion by 2034. This impressive growth represents a compound annual growth rate (CAGR) of 3.84% from 2024 to 2034, driven by a variety of...

Continue Reading